全球口周皮炎治疗市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球口周皮炎治疗市场 – 行业趋势和 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Jan 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Perioral Dermatitis Treatment Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 66.15 Million
Diagram Market Size (Forecast Year)
USD 111.14 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球口周皮炎治疗市场,按治疗(免疫抑制剂、外用伊维菌素、抗生素等)、诊断(体检、皮肤活检等)、剂量(注射、药片、软膏等)、给药途径(口服、肠胃外、外用、其他)、最终用户(医院、专科诊所、家庭护理、其他)、分销渠道(医院药房、零售药房、网上药房、其他)划分 - 行业趋势和预测到 2030 年。

口周皮炎治疗市场

口周皮炎治疗市场分析及规模

未来几年,口周皮炎的病例数量急剧增加。与此同时,生活方式或其他慢性疾病的发病率也很高,包括外用和吸入类固醇的使用增加。这些是增加口周皮炎风险的主要因素。大量使用外用类固醇是导致口周皮炎的最可能原因。

Data Bridge Market Research 分析了 2023-2030 年预测期内口周皮炎治疗市场的增长率。在上述预测期内,口周皮炎治疗市场的预期复合年增长率趋于 6.7% 左右。2022 年市场价值为 6615 万美元,到 2030 年将增长至 1.1114 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

口周皮炎治疗市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

治疗(免疫抑制剂、外用伊维菌素、抗生素等)、诊断(体检、皮肤活检等)、剂量(注射剂、药片、软膏等)、给药途径(口服、肠胃外、外用等)、最终用户(医院、专科诊所、家庭护理等)、分销渠道(医院药房、零售药房、网上药房等)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Novartis AG (Switzerland), AstraZeneca (U.K.), Merck & Co., Inc. (U.S.), Sumitomo Corporation (Japan), LEO Pharma A/S (Denmark), Cipla Inc. (U.S.), Lilly (U.S.), Bayer AG (Germany), Abbott (U.S.), Pfizer Inc. (U.S.), GSK plc (U.K.), Johnson & Johnson Private Limited (U.S.), Teva Pharmaceutical Industries Ltd.( Israel), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Bausch Health Companies Inc. (Canada), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.)

Market Opportunities

  • Increasing Cases of Rosacea

Market Definition

Perioral dermatitis is a type of rash which affects the area around the mouth and causes inflammation. The rash will extend up the nose or even into the eyes. The common symptom of this condition is a scaly or red bumpy rash. Lesions on darker skin can be hyperpigmented or brown. Antibiotics can be advantageous for a few weeks, whether oral or topically. Azelaic acid is a prescription-only topical medication. When treatment is disturbed, the problem may reoccur, but the same therapy can be restarted as needed.  

Perioral Dermatitis Treatment Market Dynamics

Drivers

  • Growing Adoption of Corticosteroids

The increase in prevalence rate of chronic diseases will lead to the growing usage of corticosteroid medications that will further enhance the enhancemnet of the growth rate. Topical or inhaled corticosteroids can activate the perioral dermatitis. Thus, this growing use is boosting the market growth.

  • Rising Healthcare Expenditure

A primary factor boosting the growth rate of perioral dermatitis treatment market is the rising healthcare expenditure which helps in improving its improved infrastructure. Furthermore, several government organizations aims to expand the healthcare infrastructure by increasing funding and this will consequently influence the market dynamics. Therefore, it boost the market growth.

Opportunities

  • Increasing Cases of Rosacea

Incidence rates for ocular involvement in rosacea patients vary from less than 10 % to more than 50 %. Cutaneous rosacea shows a strong female predominance, with the exception of phymatous rosacea, and is generally diagnosed post 30 years of age. There is a scarcity of epidemiological data on rosacea, with reported incidence rates varying from as little as 0.09% to as much as 22.00%. Thus,this creates opportunity for more treatment types.

Restraints/Challenges

  • Complications Associated with Treatment Methods

There are several medications that cause burning, itching, skin dryness, or hypopigmentation. Using the topical drug Metronidazole may surge the risk of cancer and antibiotic resistance,. Thus, all these restrain the market growth.

  • Increased Cost of Treatment

The high cost that is required for numerous treatment methods hinders market growth. Numerous market players make some huge investments in manufacturing advanced treatment techniques to increase the recovery process, and in return, the cost is increased.

本口周皮炎治疗市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关口周皮炎治疗市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

近期发展

  • 2021 年,Glenmark Pharma 已获得美国食品药品监督管理局 (FDA) 批准的仿制抗生素乳膏,名为克林霉素磷酸盐泡沫。它主要用于治疗细菌感染。克林霉素磷酸盐泡沫 (1%) 是 Mylan Pharmaceuticals Inc 的 Evoclin Foam 仿制版。

全球口周皮炎治疗市场范围

口周皮炎治疗市场根据治疗、诊断、剂量、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

治疗

  • 免疫抑制剂
  • 外用伊维菌素
  • 抗生素
  • 其他的

诊断

  • 体格检查
  • 皮肤活检
  • 其他的

剂量

  • 体格检查
  • 皮肤活检
  • 其他的

给药途径

  • 口服
  • 肠外
  • 主题
  • 其他的

最终用户

  • 医院
  • 专科诊所
  • 家庭护理
  • 其他的

分销渠道

  • 医院药房
  • 零售药店
  • 网上药店
  • 其他的

口周皮炎治疗区域分析/见解

对口周皮炎治疗市场进行了分析,并根据上述治疗、诊断、剂量、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。

口周皮炎治疗市场报告涉及的主要国家 有北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于北美地区拥有主要关键参与者和发达的医疗保健基础设施,因此在预测期内北美将占据市场主导地位。

由于患者数量不断增长、医疗保健领域的投资不断增加以及政府支持不断增加,亚太地区未来几年预计将实现增长。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。 

竞争格局和全球口周皮炎治疗份额分析

口周皮炎治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对口周皮炎治疗市场的关注有关

口周皮炎治疗市场的主要参与者包括:

  • 诺华公司(瑞士)
  • 阿斯利康(英国)
  • 默克公司(美国)
  • 住友公司(日本)
  • LEO Pharma A/S(丹麦)
  • Cipla Inc.(美国)
  • 礼来(美国)
  • 拜耳公司(德国)
  • 雅培(美国)
  • 辉瑞公司(美国)
  • 葛兰素史克公司 (英国)
  • 强生私人有限公司(美国)
  • Teva Pharmaceutical Industries Ltd.(以色列)
  • 太阳制药工业有限公司 (印度)
  • Aurobindo Pharma(印度)
  • 鲁冰花(印度)
  • Bausch Health Companies Inc.(加拿大)
  • F. Hoffmann-La Roche Ltd.(瑞士)
  • Mylan NV(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The perioral dermatitis treatment market was USD 66.15 million in 2022.
The perioral dermatitis treatment market is projected to grow at a CAGR of 6.7 % during the forecast period of 2023-2030.
The Perioral Dermatitis Treatment Market report is segmented by treatment, diagnosis, dosage, route of administration, end-users, and distribution channel.
North America is dominating the market in the forecast period because of the presence of major key players and well-developed healthcare infrastructure in this region.